Literature DB >> 25732568

Impact of Medicare's Hospital-Acquired Condition policy on infections in safety net and non-safety net hospitals.

Louise Elaine Vaz1, Kenneth P Kleinman2, Alison Tse Kawai2, Robert Jin2, William J Kassler3, Patricia S Grant4, Melisa D Rett2, Donald A Goldmann5, Michael S Calderwood2, Stephen B Soumerai2, Grace M Lee2.   

Abstract

BACKGROUND: Policymakers may wish to align healthcare payment and quality of care while minimizing unintended consequences, particularly for safety net hospitals.
OBJECTIVE: To determine whether the 2008 Centers for Medicare and Medicaid Services Hospital-Acquired Conditions policy had a differential impact on targeted healthcare-associated infection rates in safety net compared with non-safety net hospitals.
DESIGN: Interrupted time-series design. SETTING AND PARTICIPANTS: Nonfederal acute care hospitals that reported central line-associated bloodstream infection and ventilator-associated pneumonia rates to the Centers for Disease Control and Prevention's National Health Safety Network from July 1, 2007, through December 31, 2013.
RESULTS: We did not observe changes in the slope of targeted infection rates in the postpolicy period compared with the prepolicy period for either safety net (postpolicy vs prepolicy ratio, 0.96 [95% CI, 0.84-1.09]) or non-safety net (0.99 [0.90-1.10]) hospitals. Controlling for prepolicy secular trends, we did not detect differences in an immediate change at the time of the policy between safety net and non-safety net hospitals (P for 2-way interaction, .87).
CONCLUSIONS: The Centers for Medicare and Medicaid Services Hospital-Acquired Conditions policy did not have an impact, either positive or negative, on already declining rates of central line-associated bloodstream infection in safety net or non-safety net hospitals. Continued evaluations of the broad impact of payment policies on safety net hospitals will remain important as the use of financial incentives and penalties continues to expand in the United States.

Entities:  

Mesh:

Year:  2015        PMID: 25732568     DOI: 10.1017/ice.2015.38

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  7 in total

1.  Medicare's Hospital Acquired Condition Reduction Program Disproportionately Affects Minority-serving Hospitals: Variation by Race, Socioeconomic Status, and Disproportionate Share Hospital Payment Receipt.

Authors:  Cheryl K Zogg; Jyothi R Thumma; Andrew M Ryan; Justin B Dimick
Journal:  Ann Surg       Date:  2020-06       Impact factor: 12.969

2.  An exploration of community partnerships, safety-net hospitals, and readmission rates.

Authors:  Ohbet Cheon; Juha Baek; Bita A Kash; Stephen L Jones
Journal:  Health Serv Res       Date:  2020-04-05       Impact factor: 3.402

3.  The Relationship Between Parenteral Nutrition and Central Line-Associated Bloodstream Infections: 2009-2014.

Authors:  Gabriela Fonseca; Marissa Burgermaster; Elaine Larson; David S Seres
Journal:  JPEN J Parenter Enteral Nutr       Date:  2017-12-06       Impact factor: 4.016

4.  Pay for performance for hospitals.

Authors:  Tim Mathes; Dawid Pieper; Johannes Morche; Stephanie Polus; Thomas Jaschinski; Michaela Eikermann
Journal:  Cochrane Database Syst Rev       Date:  2019-07-05

5.  Knowledge, attitudes, and practice on the prevention of central line-associated bloodstream infections among nurses in oncological care: A cross-sectional study in an area of southern Italy.

Authors:  Maria Rosaria Esposito; Assunta Guillari; Italo Francesco Angelillo
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

6.  Association Between Federal Value-Based Incentive Programs and Health Care-Associated Infection Rates in Safety-Net and Non-Safety-Net Hospitals.

Authors:  Heather E Hsu; Rui Wang; Carly Broadwell; Kelly Horan; Robert Jin; Chanu Rhee; Grace M Lee
Journal:  JAMA Netw Open       Date:  2020-07-01

7.  Stethoscope disinfection is rarely done in Ethiopia: What are the associated factors?

Authors:  Biniyam Sahiledengle
Journal:  PLoS One       Date:  2019-06-27       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.